Novel imidazole derivatives with subtype-selective antimuscarinic activity

Bioorganic and Medicinal Chemistry Letters

Volumn 8, Issue 16, 1998, Pages 2163-2168

  Miyachi, Hiroyuki ^a   Kiyota, Hiromi ^a   Segawa, Mitsuru ^a  

^a KYORIN PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 (2 METHYLIMIDAZOL 1 YL) 2,2 DIPHENYLBUTYRAMIDE; IMIDAZOLE DERIVATIVE; KRP 197; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DESIGN; DRUG POTENCY; DRUG SELECTIVITY; DRUG SYNTHESIS; GUINEA PIG; HEART ATRIUM MUSCLE; ILEUM; INTESTINE MUSCLE; LIPOPHILICITY; NONHUMAN; STRUCTURE ACTIVITY RELATION;

ANIMALS; GUINEA PIGS; HEART; HEART ATRIA; ILEUM; IMIDAZOLES; KINETICS; MOLECULAR STRUCTURE; MUSCARINIC ANTAGONISTS; MUSCLE, SMOOTH; PIPERIDINES; RECEPTOR, MUSCARINIC M2; RECEPTOR, MUSCARINIC M3; RECEPTORS, MUSCARINIC; STRUCTURE-ACTIVITY RELATIONSHIP;

ANIMALIA; CAVIA PORCELLUS; SUS SCROFA;

EID: 0032544143     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(98)00393-X     Document Type: Article

References (7)

1. 1. Andersson, K, E. TIPS, 1984, 5, 521.
2. 2. Levine, R. R.; Birdsall, N. J. M. Trends Pharmacol. Sci. 1989, Dec., Supple., VII.
3. 3. Hammer, R.; Berrie, C. P.; Birdsall ,N. J. M.; Burgen, A. S. V.; Hulme, E. C. Nature (London), 1980, 283, 90.
4. 4. Barlow, R.; Berry, K. J.; Glenton, P. A. M.; Nikolaou, N. M.; Soh, K. S. A. Br.J.Pharmacol. 1976, 58, 613.
5. 5. Melchiorre, C.; Cassinelli, A.; Quaglia, W. J. Med. Chem. 1987, 30, 201
6. 6. Miyachi, H.; Kiyota, H.; Segawa, M. Bioorg. Med. Chem. Letters .in press.
7. 7. Carter, J. P.; Noronha-Blob, L.; Audia, V. H.; Dupont, A. C.; McPherson, D. W.; Rzeszotarski, W. J.; Spagnuolo, C. J.; Waid, P. P.; Kaiser, C. J. Med. Chem. 1991, 34, 3065.